Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines

Split-Face Study Comparing OnabotulinumtoxinA (Botox) and PrabotulinumtoxinA (Jeuveau) in Treating Glabellar Lines

The purpose of this study is to compare the efficacy and side effects of Botox and Jeuveau for glabellar lines.

After being informed about the study and potential risks, all patients given consent will receive Botox on one side of their face and Jueveau on the other. A random number generator will generate a list of 20 combinations of "1,2" or "2,1". "1,2" means the Botox (onabotulinumtoxin A) will be placed on the right side and "2,1" means that the Botox will be placed on the left. The other side will be injected with PrabotulinumtoxinA. 8-10 units will be injected into the designated glabella in 3 sites.

Inclusion Criteria:

• Age > 18
• Willingness to participate in the study and able to provide informed consent

Exclusion Criteria:

• Inability to follow up for study duration
• Prior neurotoxin injection in the last 4 months
• Prior surgery to the glabellar area
• Any planned aesthetic procedure to the glabellar area during the study period
• Cardiac Patients